AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-106006407/trends-amp-innovations-point.html" title="Facts and information about TRENDS & INNOVATIONS.(TO THE POINT)">TRENDS & INNOVATIONS.(TO THE POINT)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
TRENDS & INNOVATIONS.(TO THE POINT)
Smoking can delay pregnancy
Women who smoked while trying to conceive took two months longer to get pregnant than nonsmokers, Oxford University found. Women who quit a year before trying to conceive got pregnant as quickly as nonsmokers.
New cancer drug shows promise
PG-TXL showed fewer side effects and better cancer-fighting activity in early trials. Cell Therapeutics' drug is inactive in the bloodstream, but binds to tumors. That lets it deliver paciltaxel, the active ingredient in Bristol-Myers Squibb's cancer drug Taxol, where it's needed and in smaller doses. Paciltaxel has unpleasant side effects, and patients can ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Bristol-Myers Squibb Sours on Cancer-Drug Deal with ImClone Systems.
- Newspaper article from: Knight Ridder/Tribune Business News February 9, 2002 700+ words
...save face from an embarrassing biotech deal, Bristol-Myers Squibb Co. wants to back out of commitments to its sagging partner while snaring more profits from an experimental cancer drug, news reports said. Details reported Friday shed greater...
- Miami Drug Firm to Launch Generic Rival to Bristol-Myers Squibb Cancer...
- Newspaper article from: Knight Ridder/Tribune Business News Fitzgerald, Beth October 5, 2000 700+ words
...weeks the first generic competitor to the cancer medication Taxol, which generated $1.5 billion in sales for Bristol-Myers Squibb Corp. last year. In a ruling late Tuesday, a federal judge in Washington, D.C., refused to grant a injunction to...
- BRISTOL-MYERS SQUIBB ACCELERATES PRODUCTION OF ANTI-CANCER DRUG, TAXOL
- Press release article from: PR Newswire March 4, 1992 700+ words
BRISTOL-MYERS SQUIBB ACCELERATES PRODUCTION OF ANTI-CANCER DRUG, TAXOL WASHINGTON, March...R. 3836), Bristol-Myers Squibb Company (NYSE: BMY) reported...and planning, Bristol-Myers Squibb Pharmaceutical Group, said...
- Bristol-Myers Squibb Hopes to Salvage Cancer Drug.
- News wire article from: Record (Hackensack, NJ) February 26, 2002 700+ words
...In a critical meeting today with the U.S. Food and Drug Administration, Bristol-Myers Squibb Co. may learn how to salvage a promising cancer drug the agency flunked in December. The meeting involves the experimental colorectal cancer...
- Bristol-Myers Squibb, ImClone Systems Rework Cancer-Drug Deal.
- News wire article from: Record (Hackensack, NJ) March 6, 2002 700+ words
...Krauskopf Mar. 6--All might be right again between Bristol-Myers Squibb Co. and ImClone Systems Inc. After weeks of tension and negative publicity over their stalled cancer drug, Bristol-Myers and its biotech development partner agreed...
- Bristol Meyers and Exelixis Team Up.(Bristol-Myers Squibb Co. and Exelixis...
- Newspaper article from: Drug Discovery & Technology News August 1, 2001 700+ words
...molecule drugs. Bristol-Myers Squibb may also use Exelixis...Institute, Bristol- Myers Squibb. "This creative partnership...the cutting edge of cancer drug development, and we...analogue of the Bristol-Myers Squibb anticancer compound...
- MERCK KGAA WELCOMES NORTH AMERICAN PARTNERSHIP OF IMCLONE AND BRISTOL-MYERS...
- Press release article from: PR Newswire September 20, 2001 700+ words
...and commercialise the cancer drug C225 outside the US...in Japan. Bristol-Myers Squibb Co. announced yesterday...KGaA and Bristol-Myers Squibb already have a long...to another promising cancer drug in the ImClone pipeline...information about Bristol-Myers ...
- NeoTherapeutics' NeoOncoRx and Bristol-Myers Squibb Sign Agreement to Develop...
- Press release article from: PR Newswire November 5, 2001 700+ words
...Company's anti-cancer drug development subsidiary...with Bristol-Myers Squibb Company (NYSE...with Bristol-Myers Squibb on this promising...the third anti-cancer drug in phase 2 or 3...have one anti-cancer drug in a phase 3 clinical...discovered by ...
- ImClone Systems and Bristol-Myers Squibb Enter Into Landmark Commercialization...
- Press release article from: Business Wire September 19, 2001 700+ words
...commercial agreement, Bristol-Myers Squibb will pay ImClone Systems...partnership with Bristol-Myers Squibb is a landmark agreement...the worldwide leader in cancer drug development, Bristol-Myers Squibb is constantly searching...
- Erbitux to undergo more testing. (RX/News).(ImClone Systems Inc., Bristol-Myers...
- Magazine article from: Chain Drug Review October 28, 2002 700+ words
NEW YORK -- ImClone Systems Inc. and Bristol-Myers Squibb Co. are promising new tests of their controversial cancer drug in the hope of winning Food and Drug Administration approval of the product. The medication would be marketed under the...
